Search Results 51-60 of 11136 for fsa eligible

  1. SL-401 In Advanced, High Risk Myeloproliferative Neoplasms (Systemic Mastocytosis, Advanced Symptomatic Hypereosinoophic Disorder, Chronic Myelomonocytic Leukemia) - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  2. An Extension Study Of Subjects Who Received An Avalyn Inhaled Antifibrotic Agent (SAIL) - Mayo Clinic

    Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market. ... Eligible participants will have their ...

  3. Investigational Device Evaluation Of The WATCHMAN FLX™ LAA Closure Technology - Mayo Clinic

    ... eligible for long-term anti-coagulation therapy to reduce the risk of stroke but who have a rationale to seek a non-pharmacologic alternative. Participation ...

  4. A Study Of Engasertib In Moderate To Severe Hereditary Hemorrhagic Telangiectasia (HHT) - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  5. Trial Of Eltrombopag During Consolidation Therapy In Adults With AML In Complete Remission - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  6. Clinical trials - Oncology (Medical)

    Eligible patients will receive NACT with one cycle of carboplatin, followed by mirvetuximab + carboplatin (if FRα +) every 21 days for three cycles prior to ...

  7. A Study To Evaluate Tazemetostat And Pembrolizumab To Treat Advanced Urothelial Carcinoma - Mayo Clinic

    Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines ...

  8. Shared Decision Making For Fibromyalgia Patients - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  9. A Study Of LY4337713 In Participants With FAP-Positive Solid Tumors - Mayo Clinic

    Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines ...

  10. Burden of Treatment (PETS) Aim 2, Step 3: Validation of the Pilot PETS Performance Measure - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...